Global Anti-Infective Vaccines Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Anti-Infective Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-Infective Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-Infective Vaccines market in any manner.
Global Anti-Infective Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech
Market Segmentation (by Type)
Inactivated Vaccines
Conjugate Vaccines
Live/attenuated Vaccines
Market Segmentation (by Application)
Bacterial Diseases
Viral Diseases
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Infective Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Anti-Infective Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-Infective Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-Infective Vaccines market in any manner.
Global Anti-Infective Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech
Market Segmentation (by Type)
Inactivated Vaccines
Conjugate Vaccines
Live/attenuated Vaccines
Market Segmentation (by Application)
Bacterial Diseases
Viral Diseases
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-Infective Vaccines Market
- Overview of the regional outlook of the Anti-Infective Vaccines Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Infective Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-Infective Vaccines
1.2 Key Market Segments
1.2.1 Anti-Infective Vaccines Segment by Type
1.2.2 Anti-Infective Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-INFECTIVE VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-Infective Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-Infective Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-INFECTIVE VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-Infective Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-Infective Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-Infective Vaccines Sales Sites, Area Served, Product Type
3.6 Anti-Infective Vaccines Market Competitive Situation and Trends
3.6.1 Anti-Infective Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-Infective Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-INFECTIVE VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Anti-Infective Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-INFECTIVE VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-INFECTIVE VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Infective Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Anti-Infective Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Anti-Infective Vaccines Price by Type (2019-2024)
7 ANTI-INFECTIVE VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Infective Vaccines Market Sales by Application (2019-2024)
7.3 Global Anti-Infective Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-Infective Vaccines Sales Growth Rate by Application (2019-2024)
8 ANTI-INFECTIVE VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Anti-Infective Vaccines Sales by Region
8.1.1 Global Anti-Infective Vaccines Sales by Region
8.1.2 Global Anti-Infective Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-Infective Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-Infective Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-Infective Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-Infective Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-Infective Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Emergent BioDefense Operations Lansing Inc.
9.1.1 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Basic Information
9.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Overview
9.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Market Performance
9.1.4 Emergent BioDefense Operations Lansing Inc. Business Overview
9.1.5 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines SWOT Analysis
9.1.6 Emergent BioDefense Operations Lansing Inc. Recent Developments
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur Anti-Infective Vaccines Basic Information
9.2.2 Sanofi Pasteur Anti-Infective Vaccines Product Overview
9.2.3 Sanofi Pasteur Anti-Infective Vaccines Product Market Performance
9.2.4 Sanofi Pasteur Business Overview
9.2.5 Sanofi Pasteur Anti-Infective Vaccines SWOT Analysis
9.2.6 Sanofi Pasteur Recent Developments
9.3 Merck and Co.
9.3.1 Merck and Co. Anti-Infective Vaccines Basic Information
9.3.2 Merck and Co. Anti-Infective Vaccines Product Overview
9.3.3 Merck and Co. Anti-Infective Vaccines Product Market Performance
9.3.4 Merck and Co. Anti-Infective Vaccines SWOT Analysis
9.3.5 Merck and Co. Business Overview
9.3.6 Merck and Co. Recent Developments
9.4 MedImmune LLC
9.4.1 MedImmune LLC Anti-Infective Vaccines Basic Information
9.4.2 MedImmune LLC Anti-Infective Vaccines Product Overview
9.4.3 MedImmune LLC Anti-Infective Vaccines Product Market Performance
9.4.4 MedImmune LLC Business Overview
9.4.5 MedImmune LLC Recent Developments
9.5 Novartis Vaccines
9.5.1 Novartis Vaccines Anti-Infective Vaccines Basic Information
9.5.2 Novartis Vaccines Anti-Infective Vaccines Product Overview
9.5.3 Novartis Vaccines Anti-Infective Vaccines Product Market Performance
9.5.4 Novartis Vaccines Business Overview
9.5.5 Novartis Vaccines Recent Developments
9.6 Diagnostics Ltd.
9.6.1 Diagnostics Ltd. Anti-Infective Vaccines Basic Information
9.6.2 Diagnostics Ltd. Anti-Infective Vaccines Product Overview
9.6.3 Diagnostics Ltd. Anti-Infective Vaccines Product Market Performance
9.6.4 Diagnostics Ltd. Business Overview
9.6.5 Diagnostics Ltd. Recent Developments
9.7 Intercell Biomedical
9.7.1 Intercell Biomedical Anti-Infective Vaccines Basic Information
9.7.2 Intercell Biomedical Anti-Infective Vaccines Product Overview
9.7.3 Intercell Biomedical Anti-Infective Vaccines Product Market Performance
9.7.4 Intercell Biomedical Business Overview
9.7.5 Intercell Biomedical Recent Developments
9.8 MassBiologics
9.8.1 MassBiologics Anti-Infective Vaccines Basic Information
9.8.2 MassBiologics Anti-Infective Vaccines Product Overview
9.8.3 MassBiologics Anti-Infective Vaccines Product Market Performance
9.8.4 MassBiologics Business Overview
9.8.5 MassBiologics Recent Developments
9.9 Barr Labs, Inc.
9.9.1 Barr Labs, Inc. Anti-Infective Vaccines Basic Information
9.9.2 Barr Labs, Inc. Anti-Infective Vaccines Product Overview
9.9.3 Barr Labs, Inc. Anti-Infective Vaccines Product Market Performance
9.9.4 Barr Labs, Inc. Business Overview
9.9.5 Barr Labs, Inc. Recent Developments
9.10 Organon Teknika Co.
9.10.1 Organon Teknika Co. Anti-Infective Vaccines Basic Information
9.10.2 Organon Teknika Co. Anti-Infective Vaccines Product Overview
9.10.3 Organon Teknika Co. Anti-Infective Vaccines Product Market Performance
9.10.4 Organon Teknika Co. Business Overview
9.10.5 Organon Teknika Co. Recent Developments
9.11 GlaxoSmithKline Biologicals
9.11.1 GlaxoSmithKline Biologicals Anti-Infective Vaccines Basic Information
9.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Overview
9.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Market Performance
9.11.4 GlaxoSmithKline Biologicals Business Overview
9.11.5 GlaxoSmithKline Biologicals Recent Developments
9.12 CSL Ltd.
9.12.1 CSL Ltd. Anti-Infective Vaccines Basic Information
9.12.2 CSL Ltd. Anti-Infective Vaccines Product Overview
9.12.3 CSL Ltd. Anti-Infective Vaccines Product Market Performance
9.12.4 CSL Ltd. Business Overview
9.12.5 CSL Ltd. Recent Developments
9.13 ID Biomedical Co.
9.13.1 ID Biomedical Co. Anti-Infective Vaccines Basic Information
9.13.2 ID Biomedical Co. Anti-Infective Vaccines Product Overview
9.13.3 ID Biomedical Co. Anti-Infective Vaccines Product Market Performance
9.13.4 ID Biomedical Co. Business Overview
9.13.5 ID Biomedical Co. Recent Developments
9.14 Protein Sciences Co.
9.14.1 Protein Sciences Co. Anti-Infective Vaccines Basic Information
9.14.2 Protein Sciences Co. Anti-Infective Vaccines Product Overview
9.14.3 Protein Sciences Co. Anti-Infective Vaccines Product Market Performance
9.14.4 Protein Sciences Co. Business Overview
9.14.5 Protein Sciences Co. Recent Developments
9.15 Wyeth Pharmaceuticals, Inc.
9.15.1 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Basic Information
9.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Overview
9.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Market Performance
9.15.4 Wyeth Pharmaceuticals, Inc. Business Overview
9.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments
9.16 Berna Biotech
9.16.1 Berna Biotech Anti-Infective Vaccines Basic Information
9.16.2 Berna Biotech Anti-Infective Vaccines Product Overview
9.16.3 Berna Biotech Anti-Infective Vaccines Product Market Performance
9.16.4 Berna Biotech Business Overview
9.16.5 Berna Biotech Recent Developments
10 ANTI-INFECTIVE VACCINES MARKET FORECAST BY REGION
10.1 Global Anti-Infective Vaccines Market Size Forecast
10.2 Global Anti-Infective Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-Infective Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Anti-Infective Vaccines Market Size Forecast by Region
10.2.4 South America Anti-Infective Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-Infective Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-Infective Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-Infective Vaccines by Type (2025-2030)
11.1.2 Global Anti-Infective Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-Infective Vaccines by Type (2025-2030)
11.2 Global Anti-Infective Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Anti-Infective Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-Infective Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-Infective Vaccines
1.2 Key Market Segments
1.2.1 Anti-Infective Vaccines Segment by Type
1.2.2 Anti-Infective Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-INFECTIVE VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-Infective Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-Infective Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-INFECTIVE VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-Infective Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Anti-Infective Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-Infective Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-Infective Vaccines Sales Sites, Area Served, Product Type
3.6 Anti-Infective Vaccines Market Competitive Situation and Trends
3.6.1 Anti-Infective Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-Infective Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-INFECTIVE VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Anti-Infective Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-INFECTIVE VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-INFECTIVE VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Infective Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Anti-Infective Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Anti-Infective Vaccines Price by Type (2019-2024)
7 ANTI-INFECTIVE VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Infective Vaccines Market Sales by Application (2019-2024)
7.3 Global Anti-Infective Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-Infective Vaccines Sales Growth Rate by Application (2019-2024)
8 ANTI-INFECTIVE VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Anti-Infective Vaccines Sales by Region
8.1.1 Global Anti-Infective Vaccines Sales by Region
8.1.2 Global Anti-Infective Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-Infective Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-Infective Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-Infective Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-Infective Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-Infective Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Emergent BioDefense Operations Lansing Inc.
9.1.1 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Basic Information
9.1.2 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Overview
9.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Market Performance
9.1.4 Emergent BioDefense Operations Lansing Inc. Business Overview
9.1.5 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines SWOT Analysis
9.1.6 Emergent BioDefense Operations Lansing Inc. Recent Developments
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur Anti-Infective Vaccines Basic Information
9.2.2 Sanofi Pasteur Anti-Infective Vaccines Product Overview
9.2.3 Sanofi Pasteur Anti-Infective Vaccines Product Market Performance
9.2.4 Sanofi Pasteur Business Overview
9.2.5 Sanofi Pasteur Anti-Infective Vaccines SWOT Analysis
9.2.6 Sanofi Pasteur Recent Developments
9.3 Merck and Co.
9.3.1 Merck and Co. Anti-Infective Vaccines Basic Information
9.3.2 Merck and Co. Anti-Infective Vaccines Product Overview
9.3.3 Merck and Co. Anti-Infective Vaccines Product Market Performance
9.3.4 Merck and Co. Anti-Infective Vaccines SWOT Analysis
9.3.5 Merck and Co. Business Overview
9.3.6 Merck and Co. Recent Developments
9.4 MedImmune LLC
9.4.1 MedImmune LLC Anti-Infective Vaccines Basic Information
9.4.2 MedImmune LLC Anti-Infective Vaccines Product Overview
9.4.3 MedImmune LLC Anti-Infective Vaccines Product Market Performance
9.4.4 MedImmune LLC Business Overview
9.4.5 MedImmune LLC Recent Developments
9.5 Novartis Vaccines
9.5.1 Novartis Vaccines Anti-Infective Vaccines Basic Information
9.5.2 Novartis Vaccines Anti-Infective Vaccines Product Overview
9.5.3 Novartis Vaccines Anti-Infective Vaccines Product Market Performance
9.5.4 Novartis Vaccines Business Overview
9.5.5 Novartis Vaccines Recent Developments
9.6 Diagnostics Ltd.
9.6.1 Diagnostics Ltd. Anti-Infective Vaccines Basic Information
9.6.2 Diagnostics Ltd. Anti-Infective Vaccines Product Overview
9.6.3 Diagnostics Ltd. Anti-Infective Vaccines Product Market Performance
9.6.4 Diagnostics Ltd. Business Overview
9.6.5 Diagnostics Ltd. Recent Developments
9.7 Intercell Biomedical
9.7.1 Intercell Biomedical Anti-Infective Vaccines Basic Information
9.7.2 Intercell Biomedical Anti-Infective Vaccines Product Overview
9.7.3 Intercell Biomedical Anti-Infective Vaccines Product Market Performance
9.7.4 Intercell Biomedical Business Overview
9.7.5 Intercell Biomedical Recent Developments
9.8 MassBiologics
9.8.1 MassBiologics Anti-Infective Vaccines Basic Information
9.8.2 MassBiologics Anti-Infective Vaccines Product Overview
9.8.3 MassBiologics Anti-Infective Vaccines Product Market Performance
9.8.4 MassBiologics Business Overview
9.8.5 MassBiologics Recent Developments
9.9 Barr Labs, Inc.
9.9.1 Barr Labs, Inc. Anti-Infective Vaccines Basic Information
9.9.2 Barr Labs, Inc. Anti-Infective Vaccines Product Overview
9.9.3 Barr Labs, Inc. Anti-Infective Vaccines Product Market Performance
9.9.4 Barr Labs, Inc. Business Overview
9.9.5 Barr Labs, Inc. Recent Developments
9.10 Organon Teknika Co.
9.10.1 Organon Teknika Co. Anti-Infective Vaccines Basic Information
9.10.2 Organon Teknika Co. Anti-Infective Vaccines Product Overview
9.10.3 Organon Teknika Co. Anti-Infective Vaccines Product Market Performance
9.10.4 Organon Teknika Co. Business Overview
9.10.5 Organon Teknika Co. Recent Developments
9.11 GlaxoSmithKline Biologicals
9.11.1 GlaxoSmithKline Biologicals Anti-Infective Vaccines Basic Information
9.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Overview
9.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Market Performance
9.11.4 GlaxoSmithKline Biologicals Business Overview
9.11.5 GlaxoSmithKline Biologicals Recent Developments
9.12 CSL Ltd.
9.12.1 CSL Ltd. Anti-Infective Vaccines Basic Information
9.12.2 CSL Ltd. Anti-Infective Vaccines Product Overview
9.12.3 CSL Ltd. Anti-Infective Vaccines Product Market Performance
9.12.4 CSL Ltd. Business Overview
9.12.5 CSL Ltd. Recent Developments
9.13 ID Biomedical Co.
9.13.1 ID Biomedical Co. Anti-Infective Vaccines Basic Information
9.13.2 ID Biomedical Co. Anti-Infective Vaccines Product Overview
9.13.3 ID Biomedical Co. Anti-Infective Vaccines Product Market Performance
9.13.4 ID Biomedical Co. Business Overview
9.13.5 ID Biomedical Co. Recent Developments
9.14 Protein Sciences Co.
9.14.1 Protein Sciences Co. Anti-Infective Vaccines Basic Information
9.14.2 Protein Sciences Co. Anti-Infective Vaccines Product Overview
9.14.3 Protein Sciences Co. Anti-Infective Vaccines Product Market Performance
9.14.4 Protein Sciences Co. Business Overview
9.14.5 Protein Sciences Co. Recent Developments
9.15 Wyeth Pharmaceuticals, Inc.
9.15.1 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Basic Information
9.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Overview
9.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Market Performance
9.15.4 Wyeth Pharmaceuticals, Inc. Business Overview
9.15.5 Wyeth Pharmaceuticals, Inc. Recent Developments
9.16 Berna Biotech
9.16.1 Berna Biotech Anti-Infective Vaccines Basic Information
9.16.2 Berna Biotech Anti-Infective Vaccines Product Overview
9.16.3 Berna Biotech Anti-Infective Vaccines Product Market Performance
9.16.4 Berna Biotech Business Overview
9.16.5 Berna Biotech Recent Developments
10 ANTI-INFECTIVE VACCINES MARKET FORECAST BY REGION
10.1 Global Anti-Infective Vaccines Market Size Forecast
10.2 Global Anti-Infective Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-Infective Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Anti-Infective Vaccines Market Size Forecast by Region
10.2.4 South America Anti-Infective Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-Infective Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-Infective Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-Infective Vaccines by Type (2025-2030)
11.1.2 Global Anti-Infective Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-Infective Vaccines by Type (2025-2030)
11.2 Global Anti-Infective Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Anti-Infective Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-Infective Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-Infective Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Anti-Infective Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-Infective Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-Infective Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2022)
Table 10. Global Market Anti-Infective Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-Infective Vaccines Sales Sites and Area Served
Table 12. Manufacturers Anti-Infective Vaccines Product Type
Table 13. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-Infective Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-Infective Vaccines Market Challenges
Table 22. Global Anti-Infective Vaccines Sales by Type (Kilotons)
Table 23. Global Anti-Infective Vaccines Market Size by Type (M USD)
Table 24. Global Anti-Infective Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-Infective Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Anti-Infective Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-Infective Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Anti-Infective Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-Infective Vaccines Sales (Kilotons) by Application
Table 30. Global Anti-Infective Vaccines Market Size by Application
Table 31. Global Anti-Infective Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-Infective Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Anti-Infective Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-Infective Vaccines Market Share by Application (2019-2024)
Table 35. Global Anti-Infective Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-Infective Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-Infective Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Anti-Infective Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-Infective Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-Infective Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-Infective Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-Infective Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Basic Information
Table 44. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Overview
Table 45. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Emergent BioDefense Operations Lansing Inc. Business Overview
Table 47. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines SWOT Analysis
Table 48. Emergent BioDefense Operations Lansing Inc. Recent Developments
Table 49. Sanofi Pasteur Anti-Infective Vaccines Basic Information
Table 50. Sanofi Pasteur Anti-Infective Vaccines Product Overview
Table 51. Sanofi Pasteur Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi Pasteur Business Overview
Table 53. Sanofi Pasteur Anti-Infective Vaccines SWOT Analysis
Table 54. Sanofi Pasteur Recent Developments
Table 55. Merck and Co. Anti-Infective Vaccines Basic Information
Table 56. Merck and Co. Anti-Infective Vaccines Product Overview
Table 57. Merck and Co. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck and Co. Anti-Infective Vaccines SWOT Analysis
Table 59. Merck and Co. Business Overview
Table 60. Merck and Co. Recent Developments
Table 61. MedImmune LLC Anti-Infective Vaccines Basic Information
Table 62. MedImmune LLC Anti-Infective Vaccines Product Overview
Table 63. MedImmune LLC Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. MedImmune LLC Business Overview
Table 65. MedImmune LLC Recent Developments
Table 66. Novartis Vaccines Anti-Infective Vaccines Basic Information
Table 67. Novartis Vaccines Anti-Infective Vaccines Product Overview
Table 68. Novartis Vaccines Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis Vaccines Business Overview
Table 70. Novartis Vaccines Recent Developments
Table 71. Diagnostics Ltd. Anti-Infective Vaccines Basic Information
Table 72. Diagnostics Ltd. Anti-Infective Vaccines Product Overview
Table 73. Diagnostics Ltd. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Diagnostics Ltd. Business Overview
Table 75. Diagnostics Ltd. Recent Developments
Table 76. Intercell Biomedical Anti-Infective Vaccines Basic Information
Table 77. Intercell Biomedical Anti-Infective Vaccines Product Overview
Table 78. Intercell Biomedical Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Intercell Biomedical Business Overview
Table 80. Intercell Biomedical Recent Developments
Table 81. MassBiologics Anti-Infective Vaccines Basic Information
Table 82. MassBiologics Anti-Infective Vaccines Product Overview
Table 83. MassBiologics Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. MassBiologics Business Overview
Table 85. MassBiologics Recent Developments
Table 86. Barr Labs, Inc. Anti-Infective Vaccines Basic Information
Table 87. Barr Labs, Inc. Anti-Infective Vaccines Product Overview
Table 88. Barr Labs, Inc. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Barr Labs, Inc. Business Overview
Table 90. Barr Labs, Inc. Recent Developments
Table 91. Organon Teknika Co. Anti-Infective Vaccines Basic Information
Table 92. Organon Teknika Co. Anti-Infective Vaccines Product Overview
Table 93. Organon Teknika Co. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Organon Teknika Co. Business Overview
Table 95. Organon Teknika Co. Recent Developments
Table 96. GlaxoSmithKline Biologicals Anti-Infective Vaccines Basic Information
Table 97. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Overview
Table 98. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. GlaxoSmithKline Biologicals Business Overview
Table 100. GlaxoSmithKline Biologicals Recent Developments
Table 101. CSL Ltd. Anti-Infective Vaccines Basic Information
Table 102. CSL Ltd. Anti-Infective Vaccines Product Overview
Table 103. CSL Ltd. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. CSL Ltd. Business Overview
Table 105. CSL Ltd. Recent Developments
Table 106. ID Biomedical Co. Anti-Infective Vaccines Basic Information
Table 107. ID Biomedical Co. Anti-Infective Vaccines Product Overview
Table 108. ID Biomedical Co. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. ID Biomedical Co. Business Overview
Table 110. ID Biomedical Co. Recent Developments
Table 111. Protein Sciences Co. Anti-Infective Vaccines Basic Information
Table 112. Protein Sciences Co. Anti-Infective Vaccines Product Overview
Table 113. Protein Sciences Co. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Protein Sciences Co. Business Overview
Table 115. Protein Sciences Co. Recent Developments
Table 116. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Basic Information
Table 117. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Overview
Table 118. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Wyeth Pharmaceuticals, Inc. Business Overview
Table 120. Wyeth Pharmaceuticals, Inc. Recent Developments
Table 121. Berna Biotech Anti-Infective Vaccines Basic Information
Table 122. Berna Biotech Anti-Infective Vaccines Product Overview
Table 123. Berna Biotech Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Berna Biotech Business Overview
Table 125. Berna Biotech Recent Developments
Table 126. Global Anti-Infective Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Anti-Infective Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Anti-Infective Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Anti-Infective Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Anti-Infective Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Anti-Infective Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Anti-Infective Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Anti-Infective Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Anti-Infective Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Anti-Infective Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Anti-Infective Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Anti-Infective Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Anti-Infective Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Anti-Infective Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Anti-Infective Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Anti-Infective Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Anti-Infective Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-Infective Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Anti-Infective Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-Infective Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-Infective Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2022)
Table 10. Global Market Anti-Infective Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-Infective Vaccines Sales Sites and Area Served
Table 12. Manufacturers Anti-Infective Vaccines Product Type
Table 13. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-Infective Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-Infective Vaccines Market Challenges
Table 22. Global Anti-Infective Vaccines Sales by Type (Kilotons)
Table 23. Global Anti-Infective Vaccines Market Size by Type (M USD)
Table 24. Global Anti-Infective Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-Infective Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Anti-Infective Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-Infective Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Anti-Infective Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-Infective Vaccines Sales (Kilotons) by Application
Table 30. Global Anti-Infective Vaccines Market Size by Application
Table 31. Global Anti-Infective Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-Infective Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Anti-Infective Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-Infective Vaccines Market Share by Application (2019-2024)
Table 35. Global Anti-Infective Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-Infective Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-Infective Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Anti-Infective Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-Infective Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-Infective Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-Infective Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-Infective Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Basic Information
Table 44. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Product Overview
Table 45. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Emergent BioDefense Operations Lansing Inc. Business Overview
Table 47. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines SWOT Analysis
Table 48. Emergent BioDefense Operations Lansing Inc. Recent Developments
Table 49. Sanofi Pasteur Anti-Infective Vaccines Basic Information
Table 50. Sanofi Pasteur Anti-Infective Vaccines Product Overview
Table 51. Sanofi Pasteur Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi Pasteur Business Overview
Table 53. Sanofi Pasteur Anti-Infective Vaccines SWOT Analysis
Table 54. Sanofi Pasteur Recent Developments
Table 55. Merck and Co. Anti-Infective Vaccines Basic Information
Table 56. Merck and Co. Anti-Infective Vaccines Product Overview
Table 57. Merck and Co. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck and Co. Anti-Infective Vaccines SWOT Analysis
Table 59. Merck and Co. Business Overview
Table 60. Merck and Co. Recent Developments
Table 61. MedImmune LLC Anti-Infective Vaccines Basic Information
Table 62. MedImmune LLC Anti-Infective Vaccines Product Overview
Table 63. MedImmune LLC Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. MedImmune LLC Business Overview
Table 65. MedImmune LLC Recent Developments
Table 66. Novartis Vaccines Anti-Infective Vaccines Basic Information
Table 67. Novartis Vaccines Anti-Infective Vaccines Product Overview
Table 68. Novartis Vaccines Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis Vaccines Business Overview
Table 70. Novartis Vaccines Recent Developments
Table 71. Diagnostics Ltd. Anti-Infective Vaccines Basic Information
Table 72. Diagnostics Ltd. Anti-Infective Vaccines Product Overview
Table 73. Diagnostics Ltd. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Diagnostics Ltd. Business Overview
Table 75. Diagnostics Ltd. Recent Developments
Table 76. Intercell Biomedical Anti-Infective Vaccines Basic Information
Table 77. Intercell Biomedical Anti-Infective Vaccines Product Overview
Table 78. Intercell Biomedical Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Intercell Biomedical Business Overview
Table 80. Intercell Biomedical Recent Developments
Table 81. MassBiologics Anti-Infective Vaccines Basic Information
Table 82. MassBiologics Anti-Infective Vaccines Product Overview
Table 83. MassBiologics Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. MassBiologics Business Overview
Table 85. MassBiologics Recent Developments
Table 86. Barr Labs, Inc. Anti-Infective Vaccines Basic Information
Table 87. Barr Labs, Inc. Anti-Infective Vaccines Product Overview
Table 88. Barr Labs, Inc. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Barr Labs, Inc. Business Overview
Table 90. Barr Labs, Inc. Recent Developments
Table 91. Organon Teknika Co. Anti-Infective Vaccines Basic Information
Table 92. Organon Teknika Co. Anti-Infective Vaccines Product Overview
Table 93. Organon Teknika Co. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Organon Teknika Co. Business Overview
Table 95. Organon Teknika Co. Recent Developments
Table 96. GlaxoSmithKline Biologicals Anti-Infective Vaccines Basic Information
Table 97. GlaxoSmithKline Biologicals Anti-Infective Vaccines Product Overview
Table 98. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. GlaxoSmithKline Biologicals Business Overview
Table 100. GlaxoSmithKline Biologicals Recent Developments
Table 101. CSL Ltd. Anti-Infective Vaccines Basic Information
Table 102. CSL Ltd. Anti-Infective Vaccines Product Overview
Table 103. CSL Ltd. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. CSL Ltd. Business Overview
Table 105. CSL Ltd. Recent Developments
Table 106. ID Biomedical Co. Anti-Infective Vaccines Basic Information
Table 107. ID Biomedical Co. Anti-Infective Vaccines Product Overview
Table 108. ID Biomedical Co. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. ID Biomedical Co. Business Overview
Table 110. ID Biomedical Co. Recent Developments
Table 111. Protein Sciences Co. Anti-Infective Vaccines Basic Information
Table 112. Protein Sciences Co. Anti-Infective Vaccines Product Overview
Table 113. Protein Sciences Co. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Protein Sciences Co. Business Overview
Table 115. Protein Sciences Co. Recent Developments
Table 116. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Basic Information
Table 117. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Product Overview
Table 118. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Wyeth Pharmaceuticals, Inc. Business Overview
Table 120. Wyeth Pharmaceuticals, Inc. Recent Developments
Table 121. Berna Biotech Anti-Infective Vaccines Basic Information
Table 122. Berna Biotech Anti-Infective Vaccines Product Overview
Table 123. Berna Biotech Anti-Infective Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Berna Biotech Business Overview
Table 125. Berna Biotech Recent Developments
Table 126. Global Anti-Infective Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Anti-Infective Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Anti-Infective Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Anti-Infective Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Anti-Infective Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Anti-Infective Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Anti-Infective Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Anti-Infective Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Anti-Infective Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Anti-Infective Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Anti-Infective Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Anti-Infective Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Anti-Infective Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Anti-Infective Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Anti-Infective Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Anti-Infective Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Anti-Infective Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-Infective Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-Infective Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Anti-Infective Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Anti-Infective Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-Infective Vaccines Market Size by Country (M USD)
Figure 11. Anti-Infective Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Anti-Infective Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-Infective Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-Infective Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-Infective Vaccines Market Share by Type
Figure 18. Sales Market Share of Anti-Infective Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Anti-Infective Vaccines by Type in 2023
Figure 20. Market Size Share of Anti-Infective Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-Infective Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-Infective Vaccines Market Share by Application
Figure 24. Global Anti-Infective Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-Infective Vaccines Sales Market Share by Application in 2023
Figure 26. Global Anti-Infective Vaccines Market Share by Application (2019-2024)
Figure 27. Global Anti-Infective Vaccines Market Share by Application in 2023
Figure 28. Global Anti-Infective Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-Infective Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-Infective Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-Infective Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-Infective Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-Infective Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-Infective Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region in 2023
Figure 44. China Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-Infective Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-Infective Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-Infective Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-Infective Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-Infective Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-Infective Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-Infective Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-Infective Vaccines Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Anti-Infective Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-Infective Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Anti-Infective Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Anti-Infective Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-Infective Vaccines Market Size by Country (M USD)
Figure 11. Anti-Infective Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Anti-Infective Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-Infective Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-Infective Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-Infective Vaccines Market Share by Type
Figure 18. Sales Market Share of Anti-Infective Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Anti-Infective Vaccines by Type in 2023
Figure 20. Market Size Share of Anti-Infective Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-Infective Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-Infective Vaccines Market Share by Application
Figure 24. Global Anti-Infective Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-Infective Vaccines Sales Market Share by Application in 2023
Figure 26. Global Anti-Infective Vaccines Market Share by Application (2019-2024)
Figure 27. Global Anti-Infective Vaccines Market Share by Application in 2023
Figure 28. Global Anti-Infective Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-Infective Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-Infective Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-Infective Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-Infective Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-Infective Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-Infective Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region in 2023
Figure 44. China Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-Infective Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-Infective Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-Infective Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-Infective Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-Infective Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-Infective Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-Infective Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-Infective Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-Infective Vaccines Market Share Forecast by Application (2025-2030)
